
NYSEHealthcareMedical - Instruments & Supplies
最新資料
US$87.29
+US$0.88 · +1.02%
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
前收盤價
US$87.29
+US$0.88 · +1.02%
盤中時間採用ET。市場資料可能有所延遲。
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
日內區間
目前US$87.29
52週區間
目前US$87.29
盤中時間採用ET。市場資料可能有所延遲。
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
日內區間
目前US$87.29
52週區間
目前US$87.29
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 83.25億 USD | 82.54億 USD | 81.97億 USD | 81.3億 USD | 81.71億 USD |
| 銷貨成本 | 38.74億 USD | 36.61億 USD | 35.04億 USD | 34.35億 USD | 32.48億 USD |
| 毛利 | 44.51億 USD | 45.93億 USD | 46.93億 USD | 46.95億 USD | 49.23億 USD |
| 研究與開發 | 7.39億 USD | 7.75億 USD | 7.58億 USD | 7.67億 USD | 7.66億 USD |
| 銷售、一般及管理費用 | 30.8億 USD | 27.82億 USD | 22.43億 USD | 22.35億 USD | 22.78億 USD |
| 營業費用 | 22.7億 USD | 35.57億 USD | 30.01億 USD | 30.02億 USD | 30.44億 USD |
| 利息支出 | 3.47億 USD | 3.67億 USD | — | — | — |
| 折舊和攤銷 | 4.89億 USD | 5.55億 USD | 5.61億 USD | 5.78億 USD | 5.97億 USD |
| 營業利益 | 21.81億 USD | 10.36億 USD | 16.92億 USD | 16.93億 USD | 18.79億 USD |
| 淨利 | 15.56億 USD | 4.79億 USD | 13.46億 USD | 13.43億 USD | 14.6億 USD |
公司資料更新於 2026年10月11日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動,並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T241.62億0.02%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI4.26億0.02%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO3.56億0.02%1.8兆 USD0.03%US$715.59+0.61%
Vanguard Morningstar Small-Cap ETFVB3.08億0.16%1853億 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR1.96億0.29%682億 USD0.05%US$234.43+0.22%
Invesco S&P 500 Equal Weight ETFRSP1.91億0.19%977.83億 USD0.20%US$213.04+0.55%
iShares Core S&P 500 ETFIVV1.66億0.02%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY1.53億0.02%8172億 USD0.09%US$778.57+0.60%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Invesco S&P 500 Equal Weight ETFRSP
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPYAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。